Peptis Pharma LLP

Peptis Pharma LLP - research & development in Bangalore, Karnataka, India. Directors, charges & compliance details.
LLPIN AAX-3868 Incorporated 14 June 2021 ROC Bangalore HQ Bangalore, Karnataka, India
Active Limited Liability Partnership research and development
Data last updated
Contribution obligation
₹1 Lakh
As per LLP agreement
LLP age
5 yrs
Est. 2021
Designated partners
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
LLP status
Active
MCA master data
Registrar
Bangalore
ROC office
Incorporated
14 Jun 2021
Date of incorporation
Entity type
LLP
As registered with MCA

About Peptis Pharma LLP

Data last updated:

Peptis Pharma LLP is a limited liability partnership (LLP) based in Bangalore, Karnataka, India. It operates in the research and development sector. It was incorporated on 14 June 2021 and has been in existence for over 5 years.

The LLP is registered with the Registrar of Companies (ROC), Bangalore, under LLPIN AAX-3868.

The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Chenna Krishna Gundala and Sasikumar Govindannair Pottayil.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at #5 Deccan Palms Ananth Nagar Phase 2 Electronic City Phase 2 Kammasandra, Bangalore, Karnataka, India – 560100.

Company Details of Peptis Pharma LLP
LLPIN AAX-3868
Incorporation Date 14 June 2021
Total Obligation of Contribution ₹1 Lakh
ROC Bangalore
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
Key People
Chenna Krishna Gundala Designated Partner Sasikumar Govindannair Pottayil Designated Partner
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    #5 Deccan Palms Ananth Nagar Phase 2 Electronic City Phase 2 Kammasandra, Bangalore, Karnataka, India – 560100
  • Industry
    Research & Development, Research & Development
Comprehensive company report
Peptis Pharma LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Peptis Pharma LLP report

Financials, compliance, directors, charges, ownership and filings for Peptis Pharma LLP in one report.

Financials from FY 2022 Directors & ownership Charges & compliance

Financials of Peptis Pharma LLP FY 2025 filings available

Financial Statement Summary of Peptis Pharma LLP

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Income and Expenditure
Turnover••••••••••••••••
Other Income••••••••••••••••
Total Income••••••••••••••••
Purchases and Direct Costs••••••••••••••••
Personnel Expenses••••••••••••••••
Administrative Expenses••••••••••••••••
Interest••••••••••••••••
Depreciation••••••••••••••••
Total Expenses••••••••••••••••
Profit Before Tax••••••••••••••••
Tax••••••••••••••••
Profit After Tax••••••••••••••••
Profit Transferred to Partners••••••••••••••••
Assets and Liabilities
Partners' Contribution••••••••••••••••
Reserves and Surplus••••••••••••••••
Secured Loans••••••••••••••••
Unsecured Loans••••••••••••••••
Trade Payables••••••••••••••••
Other Liabilities and Provisions••••••••••••••••
Total Liabilities••••••••••••••••
Fixed Assets••••••••••••••••
Investments••••••••••••••••
Loans and Advances••••••••••••••••
Inventories••••••••••••••••
Trade Receivables••••••••••••••••
Cash and Bank Balance••••••••••••••••
Total Assets••••••••••••••••

Financial Ratios of Peptis Pharma LLP

Statement of Account and SolvencyFY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
Net Profit Margin••••••••••••••••
Return on Partners' Funds••••••••••••••••
Return on Assets••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••
Debt to Partners' Funds••••••••••••••••
Interest Coverage••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••
Receivable Days••••••••••••••••
Turnover Growth••••••••••••••••
Profit Growth••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Peptis Pharma are in the company report.

Premium access

Financial statements from FY 2022

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Designated Partners of Peptis Pharma LLP

Peptis Pharma has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Chenna Krishna Gundala
Also directs: Galoretx Pharmaceuticals Private Limited
Designated Partner14 Jun 20215 Years 4 MonthsCurrent
Sasikumar Govindannair Pottayil
Also directs: Peptyde TX Private Limited, Galoretx Pharmaceuticals Private Limited
Designated Partner14 Jun 20215 Years 4 MonthsCurrent
View all designated partners

Charges & Borrowings of Peptis Pharma LLP

Peptis Pharma LLP does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Peptis Pharma LLP

Employment history and EPFO contributions of people linked to Peptis Pharma.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Peptis Pharma LLP

Peptis Pharma LLP has 3 designated partner changes on record since 2021: 2 appointments and 1 cessation. The latest: Raghuveer Kallajhari Ramachandra ceased to be Designated Partner on 09 Jan 2024.

AGM
Peptis Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Peptis Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Raghuveer Kallajhari Ramachandra ceased to be Designated Partner.
Appointed
Chenna Krishna Gundala was appointed as Designated Partner.
Appointed
Sasikumar Govindannair Pottayil was appointed as Designated Partner.
Incorporation
14 Jun 2021
Peptis Pharma Llp was registered on 14 Jun 2021 with Roc Bangalore & aged 5 years 4 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Peptis Pharma LLP

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Peptis Pharma LLP

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Peptis Pharma LLP

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Peptis Pharma LLP

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Peptis Pharma LLP

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Peptis Pharma LLP

Peptis Pharma is an active limited liability partnership based in Bangalore, Karnataka, India. The LLP works in the research and development industry. It was incorporated on 14 June 2021 (5+ years old) and is registered under LLPIN AAX-3868.

Peptis Pharma has 2 current designated partners:

The LLPIN (Limited Liability Partnership Identification Number) of Peptis Pharma is AAX-3868. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Peptis Pharma was incorporated on 14 June 2021, making it 5+ years old. It is registered with the Registrar of Companies, Bangalore.

Raghuveer Kallajhari Ramachandra ceased to be Designated Partner on 09 Jan 2024. Chenna Krishna Gundala was appointed as Designated Partner on 14 Jun 2021. Sasikumar Govindannair Pottayil was appointed as Designated Partner on 14 Jun 2021.

The registered office of Peptis Pharma is at #5 Deccan Palms Ananth Nagar Phase 2 Electronic City Phase 2 Kammasandra, Bangalore, Karnataka, India – 560100.

The total obligation of contribution is ₹1 Lakh.

Peptis Pharma operates in the research and development industry.

Peptis Pharma can be reached at its registered office: #5 Deccan Palms Ananth Nagar Phase 2 Electronic City Phase 2 Kammasandra, Bangalore, Karnataka, India – 560100.

Peptis Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Bangalore.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available